Roni
@rjroni
Atai Life Sciences, a Nasdaq-listed biopharmaceutical company, announced plans to purchase $5 million worth of Bitcoin, with founder Christian Angermayer highlighting cryptocurrency's potential role in supporting biotech startups through lengthy regulatory processes.
0 reply
0 recast
0 reaction